CYP21A2 and neoplasm: The lack of suppression in the patient with a detected CYP21A2 variation in the current study may be due to the patient being a quick metabolizer of dexamethasone causing a decreased suppression of cortisol, and possibly another contributing factor could be the tumor size, since there is a correlation between tumor size and post-DST cortisol levels.